Read more

August 01, 2024
2 min read
Save

PAHO issues alert over spike in pertussis cases

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Pertussis cases have increased in Brazil, Mexico, Peru and the United States this year.
  • Pertussis vaccination rates dropped during COVID-19.
  • PAHO recommends 95% vaccination coverage among children.

The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.

Although North and South America together as a region had experienced an annual decline from 72,328 cases in 2012 to 3,283 cases in 2022, Brazil, Mexico, Peru and the United States reported a higher number of cases in 2024 than 2023. Specifically, in the first half of this year, the U.S. saw a 300% higher incidence of pertussis compared with the same period in 2023, and a 15% higher incidence compared with the same period in 2019. Pennsylvania reported 1,035 cases and California reported 702.

Child being vaccinated 3 Adobe Stock
The Pan American Health Organization issued an epidemiological alert because of a rise in pertussis cases. Image: Adobe Stock

Moreover, as Healio previously reported, Fayette County, Kentucky, declared a pertussis outbreak with origins in two schools this past April and May.

According to the Pan American Health Organization (PAHO), there has been a significant decline in diphtheria, tetanus and pertussis vaccination in recent years, especially during the COVID-19 pandemic. In 2021, North and South America hit a 20-year low coverage of 87% for a first dose and 81% for a third dose. Coverage increased to 90% for first dose and 88% for third dose by 2023.

The PAHO recommends countries aim for vaccination coverage of 95% among children for all three doses. The organization also recommends vaccination for health care workers and pregnant women.

The CDC recommends that children aged younger than 7 years in the U.S. receive five doses of DTaP — the first three at ages 2, 4 and 6 months and the last two at 15 to 18 months and 4 to 6 years. Older children and adults receive Tdap.

Reference: